Use of 2-octylcyanoacrylate (Dermabond) Versus 5-0 Fast Absorbing Gut During Cutaneous Wound Closure

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

50 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-07-31

Study Completion Date

2016-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether the use of 2-octylcyanoacrylate during repair of linear cutaneous surgery wounds improves scar cosmesis compared to wound closure with 5-0 fast absorbing gut.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

6-0 Fast Absorbing Gut Versus 5-0 Fast Absorbing Gut for Linear Wound Closure

NCT03303027

Surgical Wound Cosmesis

COMPLETED NA

Closure Techniques and Scar Appearance

NCT01352533

Wound Closure Techniques

WITHDRAWN NA

Comparison of Topical Skin Adhesive to Subcuticular Suture Closure of Implantable Port Incisions

NCT02212977

Port-A-Cath Placement Octylcyanoacrylate

COMPLETED NA

Comparison Study of Wound Closure at Time of Cesarean Delivery: Dermabond Glue Versus Surgical Staples

NCT00524511

Cesarean Section

TERMINATED NA

Aesthetic Outcome of Intra-dermal Versus Transcutaneous Purse-string Closure

NCT06448481

Scarring

NOT_YET_RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to determine whether the use of 2-octylcyanoacrylate during repair of linear cutaneous surgery wounds improves scar cosmesis compared to wound closure with 5-0 fast absorbing gut. The investigators will use a split wound model, where half of the wound is treated with 2-octylcyanoacrylate and the other half is repaired with 5-0 fast absorbing gut. Three-months post-surgery, the scar will be measured via the physician observer scar assessment scale, a validated scar instrument. The scar width, and adverse events will also be recorded.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Wound Closure Techniques

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Wound Closure with 2-octylcyanoacrylate

One side of the patient's wound defect will be assigned to wound closure with 2-octylcyanoacrylate liquid bonding agent).

Group Type EXPERIMENTAL

Wound Closure with 2-octylcyanoacrylate

Intervention Type PROCEDURE

Wound Closure with 5-0 Fast Absorbing Gut Sutures

Intervention Type PROCEDURE

Wound Closure with 5-0 Fast Absorbing Gut

One side of the patient's wound defect will be assigned to wound closure with 5-0 fast absorbing gut sutures.

Group Type ACTIVE_COMPARATOR

Wound Closure with 2-octylcyanoacrylate

Intervention Type PROCEDURE

Wound Closure with 5-0 Fast Absorbing Gut Sutures

Intervention Type PROCEDURE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Wound Closure with 2-octylcyanoacrylate

Intervention Type PROCEDURE

Wound Closure with 5-0 Fast Absorbing Gut Sutures

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 18 years of age or older
* Able to give informed consent themselves
* Patient scheduled for cutaneous surgical procedure with predicted linear closure of 3 cm of longer.
* Willing to return for follow-up visits

Exclusion Criteria

* Mentally handicapped
* Unable to understand written and oral English
* Incarceration
* Under 18 years of age
* Pregnant Women
* Wounds with predicted closure length less than 3 cm

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No